A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.
About This Bill
Committee
Latest Action · July 31, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.